Genovis continues to expand in Asia and has signed a distribution agreement with Chayon Laboratories Inc. for the South Korean market. The agreement covers sales from Genovis’ current and future products. It was a South Korean company that had the world’s first antibody-biosimilar approved. Since then, the market for biopharmaceuticals has continued to grow strongly […]

DANVERS, MA. Cell Signaling Technology (CST), a leading provider of antibodies, kits, and services, has opened a new office in Shanghai China to support the rapidly expanding China life science market and the growth of the CST business in the country. The new facility triples the office and warehouse footprint and will feature CST’s Global […]

DANVERS, MA — Cell Signaling Technology (CST), a leading provider of antibodies, kits, and services, has opened a new office in Shanghai China to support the rapidly expanding China life science market and the growth of the CST business in the country. The new facility triples the office and warehouse footprint and will feature CST’s […]

Dundee, UK: Ubiquigent Limited announced today that it has entered into a multi-year strategic R&D collaboration agreement with FORMA Therapeutics for the design and development of novel deubiquitylase (DUB) enzyme inhibitors. Under the terms of the collaboration agreement, Ubiquigent will receive an upfront payment with research support and is eligible for possible additional milestones payments. […]

Connection Capital, the specialist private client investment business, has raised £5.9m from its private investor clients to invest in a specialist laboratory equipment manufacturer with a global blue chip client base. HEL Ltd (HEL) designs and supplies a range of custom-made modular lab instruments and testing equipment. Typical products include different forms of “reaction stations” […]

First Research Institution to Purchase Carterra’s High-Throughput Label-Free Biosensor to Support its Novel Antibody Discovery Salt Lake City, Utah and Boston, Massachusetts. Carterra™ Inc., an innovative label-free biosensor company, and Institute for Protein Innovation (IPI) announced today that IPI has purchased a Carterra LSA™, a fully automated, label-free, high-throughput monoclonal antibody (mAb) characterization instrument. Funding for […]

Electrophoretics Ltd, a wholly owned subsidiary of Proteome Sciences plc, is pleased to announce that it has signed an amendment to the exclusive License and Distribution Agreement with Pierce Biotechnology Inc., a part of Thermo Fisher Scientific Inc., extending the current license to include intellectual property relating to a new class of higher-plex TMT® reagents […]

Microsaic Systems plc (AIM: MSYS), the developer of point of need mass spectrometry (“MS”) instruments, is pleased to announce that it has signed an agreement with Unimicro Technologies Inc. (“Unimicro”)(the “Agreement”). The Agreement covers the integration of Microsaic’s compact 4500 MiD® mass spectrometry detector with Unimicro’s Capillary Electrophoresis (“CE”) Platform. Once integrated, the combined product […]

Uppsala, Sweden and Oxford, UK: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, today announced Oxford BioMedica® plc (LSE:OXB) (“Oxford BioMedica” or “the Group”), a leading gene and cell therapy group, has invested in two Gyrolab xPlore™ systems. This is the first time the Gyrolab technology has […]

New method saves time, increases yield and purity, and reduces protein preparation costs BIRMINGHAM, Ala. — TriAltus Bioscience, LLC today announced that it has licensed a novel protein purification platform from The University of Alabama at Birmingham (UAB) and is already working to commercialize the technology. The terms of the agreement were not disclosed. Proteins are widely used in […]